NY S04513 | 2023-2024 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on February 9 2023 - 25% progression
Action: 2024-05-15 - REPORTED AND COMMITTED TO FINANCE
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on February 9 2023 - 25% progression
Action: 2024-05-15 - REPORTED AND COMMITTED TO FINANCE
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
Title
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
Sponsors
Roll Calls
2024-05-15 - Senate - Senate Health Committee Vote (Y: 13 N: 2 NV: 0 Abs: 0) [PASS]
2023-05-17 - Senate - Senate Health Committee Vote (Y: 13 N: 2 NV: 0 Abs: 0) [PASS]
2023-05-17 - Senate - Senate Health Committee Vote (Y: 13 N: 2 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-05-15 | Senate | REPORTED AND COMMITTED TO FINANCE |
2024-01-03 | Senate | REFERRED TO HEALTH |
2023-06-10 | Senate | COMMITTED TO RULES |
2023-05-22 | Senate | ADVANCED TO THIRD READING |
2023-05-18 | Senate | 2ND REPORT CAL. |
2023-05-17 | Senate | 1ST REPORT CAL.1051 |
2023-02-09 | Senate | REFERRED TO HEALTH |
Same As/Similar To
A07465 (Same As) 2024-01-03 - referred to health